Related Experiment Video
Updated: Apr 20, 2026

09:54
Fabrication of Magnetic Platforms for Micron-Scale Organization of Interconnected Neurons
Published on: July 14, 2021
5.3K
Amyloid-like fibrils labeled with magnetic nanoparticles
Biomolecular Concepts
|December 2, 2014
Summary
Researchers created magnetic nanoparticle-labeled amyloid-like fibrils for potential use as magnetic probes in medical imaging applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Molecular Biology
Background:
- Human diseases, including neurodegenerative disorders, are linked to insoluble protein aggregates like amyloid fibrils and plaques.
- Amyloid-like fibrils can be synthesized in vitro, offering a model system for studying these aggregates.
- Magnetic nanoparticles (MNPs) are increasingly used in biomedical applications due to their unique magnetic properties.
Purpose of the Study:
- To describe the preparation of amyloid-like fibrils labeled with magnetic nanoparticles.
- To explore the potential of these novel magnetic biomaterials as probes for advanced imaging techniques.
Main Methods:
- In vitro synthesis of amyloid-like fibrils.
- Conjugation of magnetic nanoparticles to the synthesized fibrils.
- Characterization of the magnetic nanoparticle-labeled fibrils.
Main Results:
- Successful preparation of amyloid-like fibrils incorporating magnetic nanoparticles.
- Demonstration of the magnetic properties of the labeled fibrils.
- Potential for targeted delivery and imaging applications.
Conclusions:
- Amyloid-like fibrils can be effectively functionalized with magnetic nanoparticles.
- These magnetic biomaterials show promise for developing novel magnetic resonance imaging (MRI) contrast agents.
- Further research could lead to new diagnostic tools for amyloid-related diseases.
Related Concept Videos
Amyloid Fibrils
13.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
13.2K
Amyloid Fibrils
7.0K
7.0K

